Search - tctmd.com

Displaying 81 - 100 of 104

Sort: Relevancy | Date

News Daily News

SORT OUT IV at 5 Years: Better Long-term Safety Confirmed for Second Generation Stents

L.A. McKeown

February 16, 2016

News Daily News

CAD Complexity Does Not Affect Dominance of Newer vs Older DES

Todd Neale

November 16, 2015

News Conference News TCT 2015

PANDA III: BuMA SES Noninferior to Excel SES for TLF at 1 Year

October 14, 2015

Presentation CCVVC 2015

Stents with Biodegradable Polymer

Presenter: Augusto Pichard

June 19, 2015

News Daily News

EuroPCR 2015 Takes on TAVR, PCI Optimization, and More

Caitlin E. Cox

May 29, 2015

Presentation TCT 2014

TCT 181: A Comparative Prospective Analysis of a Drug-Eluting Stent with Biodegradable Polymer Versus a Drug-Eluting Stent with Permanent Polymer in Bifurcation Lesions

Presenter: Bernard R. Chevalier, Leif Thuesen, Ricardo A. Costa, Ran Kornowski

September 15, 2014

Presentation TCT 2014

TCT 642: Stent Thrombosis Rates with an Abluminal Biodegradable Polymer, Biolimus-Eluting Stent Versus a Durable Polymer, Everolimus-Eluting Stent in Patients Undergoing Percutaneous Coronary Intervention: 3-Year Follow-up from the COMPARE II Trial

Presenter: Pieter C. Smits

September 14, 2014

Presentation TCT 2014

TCT 643: Very Late Stent Thrombosis After Revascularization with the Biolimus-Eluting, Biodegradable Polymer-Coated Nobori Stent Versus Durable Polymer-Coated, Sirolimus-Eluting Stents from the SORT-OUT V Trial

Presenter: Evald H. Christiansen

September 14, 2014

Presentation TCT 2014

TCT 644: Stent Thrombosis Rates of the Biodegradable Polymer, Biolimus-Eluting Stent Versus the Durable Polymer, Everolimus-Eluting Stent in All Comers Undergoing PCI: A Pooled Analysis of the COMPARE II and NEXT Trials at 1 Year

Presenter: Valentin Fuster, Pieter C. Smits

September 13, 2014

News Daily News

Similar Overall Long-Term Outcomes, Less Stent Thrombosis with Newer DES in STEMI

Todd Neale

August 22, 2014

News Conference News EuroPCR 2014

Despite Some Good News, Dedicated Stents Fail to Surpass Standard Care for Bifurcation Lesions

Caitlin E. Cox

May 20, 2014

News Daily News

TCTMD’s Top 10 Most Popular News Stories for 2013

Jason Kahn

January 27, 2014

News Conference News EuroPCR 2013

Novel Stent Helps Treat Bifurcation Lesions in FIM Registry

Jason Kahn

May 22, 2013

Presentation TCT 2013

Treatment of bifurcation lesions with a Drug Eluting Stent with biodegradable polymer.

Presenter: Fazilatum Nesa Malik, Antonio Serra, Nick West, Werner Scholtz, Farzin FATH-ORDOUBADHI, Teguh Santoso, Peep Laanmets, Werner Jung, Fraser WITHEROW, Stefan HOFFMANN, Mohsen Mohandes, Gian Battista Danzi

January 31, 2013

News Daily News

La Trombosis del Stent Causa de casi 1 de cada 10 STEMI

October 12, 2012

News Daily News

Almost 1 in 10 STEMIs Caused by Stent Thrombosis

October 12, 2012

News Daily News

First Implanted Biodegradable Stent Shows Positive Safety at 10 Years

Jason Kahn

April 17, 2012

News Daily News

El Primer Stent Biodegradable Implantado resulta Seguro a los 10 Años

Jason Kahn

April 17, 2012

News Conference News

Paclitaxel-Eluting Bioabsorbable Stent Shows Advantage over Bare-Metal Version

November 20, 2011

News Conference News

RESET: Largest Study to Date of Xience, Cypher Shows Noninferiority

August 31, 2011

Advertisement

SORT OUT IV at 5 Years: Better Long-term Safety Confirmed for Second Generation Stents

CAD Complexity Does Not Affect Dominance of Newer vs Older DES

PANDA III: BuMA SES Noninferior to Excel SES for TLF at 1 Year

Stents with Biodegradable Polymer

EuroPCR 2015 Takes on TAVR, PCI Optimization, and More

TCT 181: A Comparative Prospective Analysis of a Drug-Eluting Stent with Biodegradable Polymer Versus a Drug-Eluting Stent with Permanent Polymer in Bifurcation Lesions

TCT 642: Stent Thrombosis Rates with an Abluminal Biodegradable Polymer, Biolimus-Eluting Stent Versus a Durable Polymer, Everolimus-Eluting Stent in Patients Undergoing Percutaneous Coronary Intervention: 3-Year Follow-up from the COMPARE II Trial

TCT 643: Very Late Stent Thrombosis After Revascularization with the Biolimus-Eluting, Biodegradable Polymer-Coated Nobori Stent Versus Durable Polymer-Coated, Sirolimus-Eluting Stents from the SORT-OUT V Trial

TCT 644: Stent Thrombosis Rates of the Biodegradable Polymer, Biolimus-Eluting Stent Versus the Durable Polymer, Everolimus-Eluting Stent in All Comers Undergoing PCI: A Pooled Analysis of the COMPARE II and NEXT Trials at 1 Year

Similar Overall Long-Term Outcomes, Less Stent Thrombosis with Newer DES in STEMI

Despite Some Good News, Dedicated Stents Fail to Surpass Standard Care for Bifurcation Lesions

TCTMD’s Top 10 Most Popular News Stories for 2013

Novel Stent Helps Treat Bifurcation Lesions in FIM Registry

Treatment of bifurcation lesions with a Drug Eluting Stent with biodegradable polymer.

La Trombosis del Stent Causa de casi 1 de cada 10 STEMI

Almost 1 in 10 STEMIs Caused by Stent Thrombosis

First Implanted Biodegradable Stent Shows Positive Safety at 10 Years

El Primer Stent Biodegradable Implantado resulta Seguro a los 10 Años

Paclitaxel-Eluting Bioabsorbable Stent Shows Advantage over Bare-Metal Version

RESET: Largest Study to Date of Xience, Cypher Shows Noninferiority

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content